Fibrolamellar Hepatocellular Carcinoma (FLC)
2 clinical trials · Condition
◉ Watch Fibrolamellar Hepatocellular Carcinoma (FLC)
| Record | Firm | Date |
|---|---|---|
| Peptide Vaccine for Fibrolamellar Hepatocellular Carcinoma Patients and Other Tumor Entities Carrying the Driver Fusion DNAJB1-PRKACA (NCT06789198) | University Hospital Tuebingen | 2025-07-08 |
| DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma (NCT04248569) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-04-20 |
Track Fibrolamellar Hepatocellular Carcinoma (FLC) automatically
Every clearance here is in the API, with alerts when new ones post.